Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial

BACKGROUND: Influenza vaccines are recommended for administration by the intramuscular route. However, many physicians use the subcutaneous route for patients receiving an oral anticoagulant because this route is thought to induce fewer hemorrhagic side effects. Our aim is to assess the safety of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Casajuana, Josep, Iglesias, Begoña, Fàbregas, Mireia, Fina, Francesc, Vallès, Joan-Antoni, Aragonès, Rosa, Benítez, Mència, Zabaleta, Edurne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423363/
https://www.ncbi.nlm.nih.gov/pubmed/18507871
http://dx.doi.org/10.1186/1471-2326-8-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423363/
https://www.ncbi.nlm.nih.gov/pubmed/18507871
http://dx.doi.org/10.1186/1471-2326-8-1

Ejemplares similares